Connection
Dolores Lamb to Androgens
This is a "connection" page, showing publications Dolores Lamb has written about Androgens.
|
|
Connection Strength |
|
|
|
|
|
1.124 |
|
|
|
-
Scovell JM, Butler P, Ramasamy R, Lamb DJ. Words of wisdom. Re: Testosterone treatment is a potent tumor promoter for the rat prostate. Eur Urol. 2015 Apr; 67(4):814-5.
Score: 0.506
-
Seth A, Rivera A, Chahdi A, Choi IS, Medina-Martinez O, Lewis S, O'Neill M, Ridgeway A, Moore J, Jorgez C, Lamb DJ. Gene dosage changes in KCTD13 result in penile and testicular anomalies via diminished androgen receptor function. FASEB J. 2022 11; 36(11):e22567.
Score: 0.214
-
Kovac JR, Kovac J, Pastuszak AW, Lamb DJ, Lipshultz LI. Testosterone supplementation therapy in the treatment of patients with metabolic syndrome. Postgrad Med. 2014 Nov; 126(7):149-56.
Score: 0.123
-
Eisenberg ML, Li S, Betts P, Herder D, Lamb DJ, Lipshultz LI. Testosterone therapy and cancer risk. BJU Int. 2015 Feb; 115(2):317-21.
Score: 0.123
-
Shariat SF, Roehrborn CG, Lamb DJ, Slawin KM. Notice of duplicate publication: "Potentially harmful effect of a testosterone dietary supplement on prostate cancer growth and metastasis" (arch intern med. 2008;168[2]:235-236). Arch Intern Med. 2008 10 13; 168(18):2046-7.
Score: 0.081
-
Shariat SF, Lamb DJ, Iyengar RG, Roehrborn CG, Slawin KM. Herbal/hormonal dietary supplement possibly associated with prostate cancer progression. Clin Cancer Res. 2008 Jan 15; 14(2):607-11.
Score: 0.077
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|